טוען...
A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, etc. Trimethoprim-sulfamethoxazole (TS) is one of the most widely prescr...
שמור ב:
| הוצא לאור ב: | J Community Hosp Intern Med Perspect |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998292/ https://ncbi.nlm.nih.gov/pubmed/29915656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20009666.2018.1466598 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|